|
Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, OS
|
NIAID
|
In March 2015, HHS announced the establishment of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (Advisory Council). The Advisory Council provides advice, information, and recommendations to the Secretary regarding programs and policies intended to support and evaluate the implementation of Executive Order 13676, including the National Strategy for CARB and the National Action Plan for CARB.
|
|
President’s Emergency Plan for AIDS Relief (PEPFAR) Implementation Science/Combination Prevention
|
Research Initiative
|
CDC
|
NIAID, FIC, NCI, NIAAA, NIDA, NIMH, OD/DPCPSI/OAR
|
This President’s Emergency Plan for AIDS Relief (PEPFAR) activity focuses on testing treatment as prevention on the population level in South Africa and Zambia. This activity was initiated through the HIV Prevention Trials Network (HPTN), with support of multiple National Institutes of Health (NIH) Institutes and Centers, PEFPAR, and the Bill & Melinda Gates Foundation. The Requests for Application (RFA) was issued concurrently with a Centers for Disease Control and Prevention (CDC) RFA for combination prevention, and the agencies have worked together to ensure that the studies are complementary and do not overlap.
|
|
Preventing HIV in Adolescent Girls and Young Women Taskforce
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NICHD
|
In August 2014, the “Preventing HIV in Adolescent Girls and Young Women Task Force” was formed in response to a request from the Office of the Global AIDS Coordinator (OGAC) to articulate PEPFAR/South Africa’s strategy to address the high rates of HIV incidence and infection in 15-24 year old females. Despite slight HIV prevalence declines over the past decade young South African women continue to experience rapid increases in HIV infection rates beginning in late adolescence. Declining HIV knowledge and increased risk behavior, despite significant treatment scale up and the availability of new prevention tools, are concerning trends among young women. Representatives from NICHD, CDC and other government agencies joined the OGAC-led task force to develop the strategy and implementation plan. In December 2014, PEPFAR launched the DREAMS initiative: DREAMS is an ambitious partnership to reduce HIV infections among adolescent girls and young women in 10 sub-Saharan African countries. The goal of DREAMS is to help girls develop into Determined, Resilient, Empowered, AIDS-free, Mentored and Safe women.
|
|
Prevention Research Centers
|
Research Initiative
|
CDC
|
NCI
|
The Prevention Research Centers program funds community-based research projects at 37 academic research centers across the U.S.; 5 developmental and 32 comprehensive centers. These centers: Conduct research projects that promote health and prevent disease; Build research teams of multidisciplinary faculty; Seek solutions, strategies, and policies that address public health problems; Participate in research networks that address priority health issues, such as healthy aging, cancer prevention & control, and obesity prevention; Build long-term relationships for engaging communities as partners in research; Conduct research in directions guided by advisory boards of community leaders; Develop and deliver trainings that enhance the public health workforce; and Conduct additional research funded by other federal agencies, foundations, and nonprofit organizations.
|
|
Prevention Research Coordinating Committee (PRCC)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, OS
|
OD/DPCPSI/ODP, CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OAR, OD/DPCPSI/OBSSR, OD/DPCPSI/ODS, OD/DPCPSI/ORWH, OD/OLPA
|
The NIH Prevention Research Coordinating Committee (PRCC) serves as a venue for exchanging programmatic and scientific information of interest to the NIH, as well as for planning and implementation of collaborative activities. As a trans-NIH committee, the PRCC provides a broad perspective on the current state-of-the-science, and disseminates to NIH Institutes and Centers information about prevention-related activities sponsored by Federal and non-Federal organizations. The PRCC also serves as an advisory body to the Director of ODP and makes recommendations regarding scientific, programmatic, and policy issues. ODP coordinates the activities of the PRCC.
|
|
Prevention with Positives Intervention HIV Clinics (Y01-MH-1318)
|
Research Initiative
|
CDC
|
NIMH, NIAID
|
The Prevention with Positives Intervention HIV Clinics is a collaboration between the National Institute of Mental Health (NIMH) and the Centers for Disease Control and Prevention (CDC) to conduct an HIV clinic-based comparison of a comprehensive prevention program for people living with HIV, targeting multiple health behaviors (sexual risk, medication adherence, clinic attendance) and health outcomes (viral load, retention in care). In fiscal year 2016, data collection at six HIV clinics in the U.S. was completed, and the data will be analyzed for publication.
|
|
Priorities for National HIV/AIDS Strategy 2020 Research and Programmatic Agenda for Mental Health and Substance Use Concerns
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA, SAMHSA
|
NIMH, NIAID, NIDA
|
The Department of Health and Human Services (HHS) Interagency HIV, Mental Health, and Substance Use Concerns Work Group, which grew out of the National HIV/AIDS Strategy (NHAS), updated to 2020, includes participation from the Centers for Disease Control and Prevention (CDC), Health Services Resources Administration (HRSA), Substance Abuse and Mental Health Services Administration (SAMHSA), and National Institutes of Health (NIH). The work group identified priorities within four themes: (1) Screening; (2) Integrated Care and Prevention Services; (3) Anti-Stigma/Anti-Discrimination; and, (4) Addressing the Special Needs of Key Populations and Other Populations Heavily Affected by HIV. Priorities were written broadly to allow assessment, assurance, policy, and research strategies to be developed as needed or prioritized by each agency. Improving prevention and treatment outcomes for HIV, mental and substance use disorders, co-occurring disorders, and other problems is inherent in all priorities, as well. HIV prevention is focused on communities and populations with increased HIV incidence and prevalence, and HIV care and treatment is aimed at the HIV care continuum from testing to viral suppression, and continued care. Research goals include developing and testing novel and innovative interventions. Another focus is delivery of evidence-based services and practices to the relevant communities and populations.
|
|
Promoting Semantic Interoperability of Laboratory Data Test Results
|
Resource Development
|
CDC, FDA
|
NLM
|
CDC and NLM encourage considering ways that FDA could accelerate specifications of LOINC codes that apply to each test result that a lab/test instrument or kit can generate. Availability of the right LOINC codes with each instrument test kit will greatly simplify the correct assignment of codes by laboratory for sending to clinician''s medical record system.
|
|
Public Health and Emergency Medical Countermeasures Enterprise (PHEMCE)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC, FDA, OS, SAMHSA
|
NIAID, NIAMS, NICHD, NINDS, NLM
|
The PHEMCE advances national preparedness for natural, accidental, and intentional threats by coordinating medical countermeasure-related efforts within HHS and in cooperation with PHEMCE interagency partners. NIAID has representatives on many groups within PHEMCE.
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Chemical Integrated Product Development Team (IPT)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NINDS, NIAID
|
The U.S. Department of Health and Human Services (HHS) Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) leads the mission to develop and acquire medical countermeasures that will improve public health emergency preparedness as well as prevent and mitigate the adverse health consequences associated with chemical, biological, radiological and nuclear (CBRN), and naturally occurring threats.
|